BNGOWのチャート
BNGOWの企業情報
| symbol | BNGOW |
|---|---|
| 会社名 | |
| 分野（sector） | Capital Goods 資本財（工業製品） |
| 産業（industry） | Biotechnology: Laboratory Analytical Instruments |
| 業種 | ― |
| 概要 | 事業概要 -- |
| 本社所在地 | -- |
| 代表者氏名 | ― |
| 代表者役職名 | ― |
| 電話番号 | ― |
| 設立年月日 | -- |
| 市場名 | -- |
| ipoyear | 2018年 |
| 従業員数 | - |
| url | ― |
| nasdaq_url | https://www.nasdaq.com/symbol/bngow |
| adr_tso | ― |
| EBITDA | EBITDA ー |
| 終値（lastsale） | 2.75 |
| 時価総額（marketcap） | 0 |
| 時価総額 | 時価総額 ― |
| 売上高 | 売上高 -- |
| 企業価値(EV) | 企業価値(EV) ー |
| 当期純利益 | 当期純利益 -- |
| 決算概要 | 決算概要 -- |
BNGOWのテクニカル分析
BNGOWのニュース
The Buzz Show: Bionano Genomics, Inc. (NASDAQ: BNGO) Joins US Small-Cap Russell 2000® Index 2021/06/28 21:55:27 Financial Buzz
FinancialBuzz.coms latest The Buzz Show: Featuring Our Corporate News Recap on Bionano Genomics, Inc. up 6% after Becoming a Member of US Small-Cap Russell 2000® Index Bionano Genomics, Inc. (NASDAQ: BNGO) gained over 6% in premarket trading after the Company said it was added as a member of the US small-cap Russell 2000® Index, effective The post The Buzz Show: Bionano Genomics, Inc. (NASDAQ: BNGO) Joins US Small-Cap Russell 2000® Index first appeared on Financial Buzz .
Bionano Genomics (BNGO.Q), a Small Cap Biotechnology Company with Big Potential 2021/06/28 16:08:08 Equity Guru
Bionano Genomics (BNGO.Q), a genome analysis company providing tools and services to scientists and clinicians, announced today that it has been added as a member of the US small-cap Russell 2000® Index. We are pleased Bionano has been added to the Russell indexes, which means Bionanos share performance is now included in a leading benchmark [] The post Bionano Genomics (BNGO.Q), a Small Cap Biotechnology Company with Big Potential appeared first on Equity.Guru .
Why Bionano Genomics, CorMedix and Eloxx Are Moving Friday 2021/05/14 14:27:47 Benzinga
Bionano Genomics, Inc. (NASDAQ: Full story available on Benzinga.com
Bionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue Estimates 2021/05/13 22:15:10 Yahoo Finance
Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of 0.00% and 13.14%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Does Bionano Genomics Deserve a Place in Your Portfolio? 2021/04/29 22:30:45 Investing.com
https://www.investing.com/news/stock-market-news/does-bionano-genomics-deserve-a-place-in-your-portfolio-2490760
Why Cyclerion, Sol-Gel, Aldeyra, DermTech and Bionano Genomics Are Moving Today 2021/04/27 16:03:22 Benzinga
Cyclerion Therapeutics, Inc. (NASDAQ: CYCN ), Sol-Gel Technologies Ltd. (NASDAQ: SLGL ), Aldeyra Therapeutics, Inc. (NASDAQ: ALDX ), DermTech, Inc. (NASDAQ: DMTK ) and Bionano Genomics, Inc. (NASDAQ: BNGO ) are among the biggest health care movers Tuesday. Cyclerion Slips On Study Delay: Cyclerion, a clinical-stage biopharma developing treatments for restoring cognitive functions, provided a clinical pipeline update. The company delved on the development strategy and execution for its lead asset CY6463, which is being evaluated in Alzheimer's disease with vascular pathology as well as mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes, or MELAS. The MELAS study is enrolling more slowly than initially projected, primarily due to COVID-19, the company said. It now expects to report data from the Phase 2a pilot study by year-end 2021. Cyclerion shares were slipping 16.39% to $2.60. Sol-Gel Down On Potential Delay In FDA Decision: Sol-Gel's new drug application for Epsolay in the …
What's Going On With Bionano Genomics Stock Today? 2021/04/26 18:49:25 Benzinga
BioNano Genomics Inc (NASDAQ: BNGO ) shares are trading higher by 19.5% at … Full story available on Benzinga.com
Why Bionano Genomics, CorMedix and Eloxx Are Moving Friday 2021/05/14 14:27:47 Benzinga
Bionano Genomics, Inc. (NASDAQ: Full story available on Benzinga.com
Bionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue Estimates 2021/05/13 22:15:10 Yahoo Finance
Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of 0.00% and 13.14%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Does Bionano Genomics Deserve a Place in Your Portfolio? 2021/04/29 22:30:45 Investing.com
https://www.investing.com/news/stock-market-news/does-bionano-genomics-deserve-a-place-in-your-portfolio-2490760
Why Cyclerion, Sol-Gel, Aldeyra, DermTech and Bionano Genomics Are Moving Today 2021/04/27 16:03:22 Benzinga
Cyclerion Therapeutics, Inc. (NASDAQ: CYCN ), Sol-Gel Technologies Ltd. (NASDAQ: SLGL ), Aldeyra Therapeutics, Inc. (NASDAQ: ALDX ), DermTech, Inc. (NASDAQ: DMTK ) and Bionano Genomics, Inc. (NASDAQ: BNGO ) are among the biggest health care movers Tuesday. Cyclerion Slips On Study Delay: Cyclerion, a clinical-stage biopharma developing treatments for restoring cognitive functions, provided a clinical pipeline update. The company delved on the development strategy and execution for its lead asset CY6463, which is being evaluated in Alzheimer's disease with vascular pathology as well as mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes, or MELAS. The MELAS study is enrolling more slowly than initially projected, primarily due to COVID-19, the company said. It now expects to report data from the Phase 2a pilot study by year-end 2021. Cyclerion shares were slipping 16.39% to $2.60. Sol-Gel Down On Potential Delay In FDA Decision: Sol-Gel's new drug application for Epsolay in the …